The denominator in early phase CAR T-cell trials examining novel target antigens

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2023-07, Vol.402 (10399), p.354-356
1. Verfasser:	Abid, Muhammad Bilal
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Antigens, CD19 Apheresis Aplasia Biocompatibility CD19 antigen CD20 antigen CD22 antigen Cell therapy Clinical trials Costs Cytokines Drug dosages Durability Emergency medical care Emergency medical services Fatalities Humans Immune reconstitution Immunoglobulins Infections Intravenous administration Lymphocytes B Lymphocytes T Lymphopenia Malignancy Mortality Neutropenia Patients Quality of life Receptors, Antigen, T-Cell Remission Remission (Medicine) Response rates Survival T-Lymphocytes Thrombocytopenia Toxicity Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!